Smart Device-based Cardiac Rehabilitation After Myocardial Intervention
- Conditions
- Myocardial Infarction
- Interventions
- Device: Smart device-based cardiac rehabilitation
- Registration Number
- NCT03926312
- Lead Sponsor
- Charles University, Czech Republic
- Brief Summary
The aim of this study is to evaluate the influence of cardiac rehabilitation based on smart band use and telemonitoring on functional capacity change and risk factors control among patients hospitalized for acute myocardial infarction.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 64
- Signed informed consent with the study
- Men and women >18 years of age
- Patients ≥1 and ≤6 months after type I myocardial infarction
- Physical inactivity before MI defined as the absence of moderate to vigorous exercise for at least 30 minutes 5 or more days a week
- Heart failure NYHA IIIB-IV
- Planned coronary revascularization
- Planned major surgery within the next 12 months
- Inability to walk for any reason
- Comorbidities that would preclude adherence to the rehabilitation program (e.g. arthrosis, active malignancy, major depression or other significant psychiatric disorder, cognitive impairment) - at the discretion of the physician
- Life expectancy less than 12 months
- Pregnancy
- Inability to operate the smart-watch
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Smart device-based rehabilitation Smart device-based cardiac rehabilitation One month after myocardial infarction, patients will receive a smart band and a cellphone in order to transmit data on physical activity to electronic health record. A study nurse will periodically check compliance with recommended physical activity and intervene in the case of non-compliance.
- Primary Outcome Measures
Name Time Method Functional capacity change 3 months 6-minute walk test distance and maximal oxygen consumption (VO2 max) change after 3 months of the intervention
- Secondary Outcome Measures
Name Time Method Body fat percentage 3 months Body fat percentage change after 3 months of the intervention
Waist circumference 3 months Waist circumference change after 3 months of the intervention
Blood pressure 3 months Blood pressure change after 3 months of the intervention
Smoking cessation 3 months Smoking cessation after 3 months of the intervention
Lipid levels 3 months Lipid levels change after 3 months of the intervention
Glycated hemoglobin 3 months Glycated hemoglobin change after 3 months of the intervention
Trial Locations
- Locations (1)
Institute for Clinical and Experimental Medicine
🇨🇿Prague, CZEC, Czechia